Order Entry
ContactUsLinkComponent
Steatosis Colorimetric Assay Kit, Cayman Chemical
Steatosis Colorimetric Assay Kit, Cayman Chemical
# de catalogue 75817-252
Numéro CAS:  
KIT STEATOSIS COLORIMETRIC ASSAY 4 DEG C
Steatosis Colorimetric Assay Kit, Cayman Chemical
# de catalogue 75817-252
Numéro CAS:  
Restricted Products: To process your orders without delay, please provide the required business documentation to purchase this product.

To order chemicals, medical devices, or other restricted products please provide ID that includes your business name & shipping address via email [email protected] or fax 484.881.5997 referencing your VWR account number. Acceptable forms of ID are:

  • • State issued document with your organization's Federal Tax ID Number
  • • State issued document with your organization's Resale Tax ID Number
  • • City or County issued Business License
  • • State Department of Health Services License
  • • Any other ID issued by the State that includes the business name & address

* ATTN: California Customers may require additional documentation as part of the CA Health & Safety Code. Products that fall under this regulation will be placed on a mandatory 21-day hold after documentation is received. VWR will not lift restrictions for residential shipping addresses.

Spécifications

  • Cat. no.:
    75817-252
  • Includes:
    Kit contains: Positive Control, Wash Solution, and Reagents
  • Supplier No.:
    10012643-1

Spécifications

A propos de cet article

A colorimetric screening assay for hepatoxicity assessment.

  • Detect excessive lipid accumulation in cells
  • Assess by microscopy or plate reader
  • An inducer of lipid accumulation is included as a positive control

Steatosis, also known as fatty liver, is a pathological process characterized by abnormal accumulation of lipid within cells. While simple steatosis may not be associated with significant impairment of liver function, excessive fat accumulation can lead to cirrhosis and even liver failure. The molecular mechanisms involved in non-alcoholic steatosis are poorly understood and little information is available on the pathway(s) responsible for progressive hepatocellular damage following lipid accumulation. Determining hepatotoxicity is an essential component of the drug discovery process and includes steatosis as one of the key parameters evaluated. Cayman’s Steatosis Colorimetric Assay Kit provides a convenient tool for evaluating steatosis risk of drug candidates. In this assay, Oil Red O is used to stain neutral lipids in hepatocytes. Lipid accumulation is then quantified using a plate reader after the dye is extracted from the lipid droplets. Chloroquine is included in the kit as a positive control.

Customers Who Bought This Also Bought